Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. BRZE
3. CHYM
4. USO
5. QCOM
6. IRT
7. ASO
8. UNFI
9. SPY
10. EVMN

Go back to Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million
(NASDAQ: RCKT) Delayed: 3.73 +0.02 (0.54%)
Previous Close $3.71    52 Week High $ 
Open $3.67    52 Week Low $ 
Day High $3.76    P/E N/A 
Day Low $3.62    EPS $ 
Volume 209,136